Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 872381108 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Ew Healthcare Partners Fund 2, L.P.
13D
|
17.2% |
6/9/2026
Event 6/9/2026
|
||
| Ew Healthcare Partners Fund 2, L.P. | 6.8% | |||
| Ew Healthcare Partners Fund 2-A, L.P. | 10.5% | |||
| EW Healthcare Partners Fund 2-GP, L.P. | 17.2% | |||
| EW Healthcare Partners Fund 2-UGP, LLC | 17.2% | |||
|
Nantahala Capital Management, LLC
13G/A
|
12.9% |
8/14/2026
Event 6/30/2026
|
||
| Nantahala Capital Management, LLC | 12.9% | |||
| Wilmot B. Harkey | 12.9% | |||
| Daniel Mack | 12.9% | |||
|
North Run Capital, LP
13G/A
|
9.3% |
5/30/2025
Event 3/31/2025
|
||
| North Run Capital, LP | 9.3% | |||
| North Run Advisors, LLC | 9.3% | |||
| North Run - Due North Partners, LP | 9.3% | |||
| North Run GP, LP | 9.3% | |||
| Todd B. Hammer | 9.3% | |||
| Thomas B. Ellis | 9.3% | |||
| Michael Bosco | 9.3% | |||
|
Stonepine Capital Management, LLC
13G/A
|
6.0% |
2/13/2025
Event 12/31/2024
|
||
| Stonepine Capital Management, LLC | 6.0% | |||
| Stonepine Capital, L.P. | 6.0% | |||
| Stonepine GP, LLC | 6.0% | |||
| Jon M. Plexico | 6.0% | |||
| Lytton, Laurence W. 13G/A | 5.5% |
5/15/2026
Event 3/31/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
SilverArc Capital Management, LLC
13G/A
|
4.8% |
8/14/2026
Event 6/30/2026
|
||
| SilverArc Capital Management, LLC | 4.8% | |||
| Devesh Gandhi | 4.8% | |||
|
Orin Hirschman
13G/A
|
3.6% |
5/8/2025
Event 3/31/2025
|
||
| Orin Hirschman | 3.6% | |||
| AIGH Capital Management LLC | 3.6% | |||
| Grow Funds, LLC. 13G/A |
Checked 5% or less
|
10/15/2025
Event 9/30/2025
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 46 | 31.6 M | $23.7 M |
| 2026 Q1 | 37 | 26.9 M | $16.7 M |
| 2025 Q4 | 43 | 27.6 M | $32.5 M |
| 2025 Q3 | 42 | 23.6 M | $35.1 M |
| 2025 Q2 | 50 | 23.5 M | $45.5 M |
| 2025 Q1 | 54 | 24.6 M | $30.0 M |
| 2024 Q4 | 52 | 27.2 M | $82.0 M |
| 2024 Q3 | 54 | 18.0 M | $45.6 M |
| 2024 Q2 | 74 | 22.3 M | $105 M |
| 2024 Q1 | 64 | 20.8 M | $118 M |
| 2023 Q4 | 64 | 22.2 M | $147 M |
| 2023 Q3 | 71 | 21.9 M | $175 M |
| 2023 Q2 | 70 | 22.1 M | $223 M |
| 2023 Q1 | 57 | 16.9 M | $180 M |
| 2022 Q4 | 51 | 17.5 M | $201 M |
| 2022 Q3 | 46 | 16.8 M | $143 M |
| 2022 Q2 | 33 | 13.5 M | $95.0 M |
| 2022 Q1 | 31 | 11.2 M | $130 M |
| 2021 Q4 | 38 | 10.6 M | $135 M |
| 2021 Q3 | 38 | 10.2 M | $140 M |
| 2021 Q2 | 46 | 10.2 M | $165 M |
| 2021 Q1 | 48 | 9.89 M | $147 M |
| 2020 Q4 | 48 | 9.69 M | $146 M |
| 2020 Q3 | 45 | 9.75 M | $161 M |
| 2020 Q2 | 51 | 9.89 M | $128 M |
| 2020 Q1 | 31 | 6.50 M | $50.7 M |
| 2019 Q4 | 24 | 6.41 M | $83.0 M |